Found: 4
Select item for more details and to access through your institution.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01046-2
- By:
- Publication type:
- Article
Plasma Cell Leukemia: Definition, Presentation, and Treatment.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0754-x
- By:
- Publication type:
- Article
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5585, doi. 10.3390/cancers15235585
- By:
- Publication type:
- Article
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3‐Month Results from an Open Label Phase 2 Study.
- Published in:
- Journal of Bone & Mineral Research, 2023, v. 38, n. 5, p. 639, doi. 10.1002/jbmr.4807
- By:
- Publication type:
- Article